Search - tctmd.com

Displaying 441 - 460 of 1038

Sort: Relevancy | Date

News Industry News

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

October 14, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

L.A. McKeown

October 10, 2014

News Daily News

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

L.A. McKeown

October 10, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Industry News

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

October 08, 2014

News Daily News

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

October 03, 2014

News Daily News

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Caitlin E. Cox

October 03, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

News Conference News TCT 2014

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

September 17, 2014

News Industry News

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

September 17, 2014

Presentation TCT 2014

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Miha Cercek

September 16, 2014

News Industry News

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

September 16, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

Presentation TCT 2014

Case #1: Targeting Massive Thrombus in Cardiogenic Shock

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, Goran K. Olivecrona

September 15, 2014

News Conference News TCT 2014

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

Advertisement

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Case #1: Targeting Massive Thrombus in Cardiogenic Shock

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content